Financial Instruments: | 3 Months Ended |
Mar. 31, 2014 |
Financial Instruments: | ' |
Financial Instruments: | ' |
3. Financial Instruments: |
|
Fair Value Measurements |
|
Accounting guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, the company is required to classify certain assets and liabilities based on the following fair value hierarchy: |
|
Level 1—Quoted prices (unadjusted) in active markets for identical assets or liabilities that can be accessed at the measurement date; |
Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and |
Level 3—Unobservable inputs for the asset or liability. |
|
The guidance requires the use of observable market data if such data is available without undue cost and effort. |
|
When available, the company uses unadjusted quoted market prices in active markets to measure the fair value and classifies such items within Level 1. If quoted market prices are not available, fair value is based upon internally developed models that use current market-based or independently sourced market parameters such as interest rates and currency rates. Items valued using internally generated models are classified according to the lowest level input or value driver that is significant to the valuation. |
|
The determination of fair value considers various factors including interest rate yield curves and time value underlying the financial instruments. For derivatives and debt securities, the company uses a discounted cash flow analysis using discount rates commensurate with the duration of the instrument. |
|
In determining the fair value of financial instruments, the company considers certain market valuation adjustments to the “base valuations” calculated using the methodologies described below for several parameters that market participants would consider in determining fair value: |
|
Counterparty credit risk adjustments are applied to financial instruments, taking into account the actual credit risk of a counterparty as observed in the credit default swap market to determine the true fair value of such an instrument. |
Credit risk adjustments are applied to reflect the company’s own credit risk when valuing all liabilities measured at fair value. The methodology is consistent with that applied in developing counterparty credit risk adjustments, but incorporates the company’s own credit risk as observed in the credit default swap market. |
|
As an example, the fair value of derivatives is derived utilizing a discounted cash flow model that uses observable market inputs such as known notional value amounts, yield curves, spot and forward exchange rates as well as discount rates. These inputs relate to liquid, heavily traded currencies with active markets which are available for the full term of the derivative. |
|
Certain financial assets are measured at fair value on a nonrecurring basis. These assets include equity method investments that are recognized at fair value at the measurement date to the extent that they are deemed to be other-than-temporarily impaired. Certain assets that are measured at fair value on a recurring basis can be subject to nonrecurring fair value measurements. These assets include available-for-sale equity investments that are deemed to be other-than-temporarily impaired. In the event of an other-than-temporary impairment of a financial investment, fair value is measured using a model described above. |
|
Non-financial assets such as property, plant and equipment, land, goodwill and intangible assets are also subject to nonrecurring fair value measurements if they are deemed to be impaired. The impairment models used for nonfinancial assets depend on the type of asset. See Note A, “Significant Accounting Policies - Impairment,” on page 88 in the company’s 2013 Annual Report for additional information. There were no material impairments of non-financial assets for the three months ended March 31, 2014 and 2013, respectively. |
|
Accounting guidance permits the measurement of eligible financial assets, financial liabilities and firm commitments at fair value, on an instrument-by-instrument basis, that are otherwise not permitted to be accounted for at fair value under other accounting standards. This election is irrevocable. The company has not applied the fair value option to any eligible assets or liabilities. |
|
The following tables present the company’s financial assets and financial liabilities that are measured at fair value on a recurring basis at March 31, 2014 and December 31, 2013. |
(Dollars in millions) | | | | | | | | | | | | | | | | | | | |
At March 31, 2014 | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | | | | | | | |
Assets: | | | | | | | | | | | | | | | | | | | |
| Cash equivalents (1) | | | | | | | | | | | | | | | | | | | |
| | Time deposits and certificates of deposit | | $ | — | | $ | 4,619 | | $ | — | | $ | 4,619 | | | | | | | |
| | Commercial paper | | | — | | | 559 | | | — | | | 559 | | | | | | | |
| | Money market funds | | | 988 | | | — | | | — | | | 988 | | | | | | | |
| | U.S. government securities | | | — | | | 599 | | | — | | | 599 | | | | | | | |
| | Canadian government securities | | | — | | | 226 | | | — | | | 226 | | | | | | | |
| | Other securities | | | — | | | 40 | | | — | | | 40 | | | | | | | |
| Total | | | 988 | | | 6,044 | | | — | | | 7,032 | -6 | | | | | | |
| Debt securities - current (2) | | | — | | | 295 | | | — | | | 295 | -6 | | | | | | |
| Debt securities - noncurrent (3) | | | 1 | | | 8 | | | — | | | 9 | | | | | | | |
| Trading securities investments (3) | | | — | | | 77 | | | — | | | 77 | | | | | | | |
| Available-for-sale equity investments (3) | | | 4 | | | — | | | — | | | 4 | | | | | | | |
| Derivative assets (4) | | | | | | | | | | | | | | | | | | | |
| | Interest rate contracts | | | — | | | 363 | | | — | | | 363 | | | | | | | |
| | Foreign exchange contracts | | | — | | | 297 | | | — | | | 297 | | | | | | | |
| | Equity contracts | | | — | | | 17 | | | — | | | 17 | | | | | | | |
| Total | | | — | | | 678 | | | — | | | 678 | -7 | | | | | | |
Total assets | | $ | 993 | | $ | 7,102 | | $ | — | | $ | 8,095 | -7 | | | | | | |
Liabilities: | | | | | | | | | | | | | | | | | | | |
| Derivative liabilities (5) | | | | | | | | | | | | | | | | | | | |
| | Foreign exchange contracts | | $ | — | | $ | 427 | | $ | — | | $ | 427 | | | | | | | |
| | Equity contracts | | | — | | | 2 | | | — | | | 2 | | | | | | | |
| | Interest rate contracts | | | — | | | 12 | | | — | | | 12 | | | | | | | |
Total liabilities | | $ | — | | $ | 441 | | $ | — | | $ | 441 | -7 | | | | | | |
(1) Included within cash and cash equivalents in the Consolidated Statement of Financial Position. |
(2) Commercial paper and certificates of deposit reported as marketable securities in the Consolidated Statement of |
Financial Position. |
(3) Included within investments and sundry assets in the Consolidated Statement of Financial Position. |
(4) The gross balances of derivative assets contained within prepaid expenses and other current assets, and investments |
and sundry assets in the Consolidated Statement of Financial Position at March 31, 2014 were $202 million and |
$476 million, respectively. |
(5) The gross balances of derivative liabilities contained within other accrued expenses and liabilities, and other |
liabilities in the Consolidated Statement of Financial Position at March 31, 2014 were $370 million and $71 |
million, respectively. |
(6) Available-for-sale securities with carrying values that approximate fair value. |
(7) If derivative exposures covered by a qualifying master netting agreement had been netted in the Consolidated |
Statement of Financial Position, the total derivative asset and liability positions would have been reduced by $221 |
million each. |
|
(Dollars in millions) | | | | | | | | | | | | | | | | | | | |
At December 31, 2013 | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | | | | | | | |
Assets: | | | | | | | | | | | | | | | | | | | |
| Cash equivalents (1) | | | | | | | | | | | | | | | | | | | |
| | Time deposits and certificates of deposit | | $ | — | | $ | 4,754 | | $ | — | | $ | 4,754 | | | | | | | |
| | Commercial paper | | | — | | | 1,507 | | | — | | | 1,507 | | | | | | | |
| | Money market funds | | | 1,728 | | | — | | | — | | | 1,728 | | | | | | | |
| | Other securities | | | — | | | 8 | | | — | | | 8 | | | | | | | |
| Total | | | 1,728 | | | 6,269 | | | — | | | 7,997 | -6 | | | | | | |
| Debt securities - current (2) | | | — | | | 350 | | | — | | | 350 | -6 | | | | | | |
| Debt securities - noncurrent (3) | | | 1 | | | 7 | | | — | | | 9 | | | | | | | |
| Available-for-sale equity investments (3) | | | 18 | | | — | | | — | | | 18 | | | | | | | |
| Derivative assets (4) | | | | | | | | | | | | | | | | | | | |
| | Interest rate contracts | | | — | | | 308 | | | — | | | 308 | | | | | | | |
| | Foreign exchange contracts | | | — | | | 375 | | | — | | | 375 | | | | | | | |
| | Equity contracts | | | — | | | 36 | | | — | | | 36 | | | | | | | |
| Total | | | — | | | 719 | | | — | | | 719 | -7 | | | | | | |
Total assets | | $ | 1,747 | | $ | 7,345 | | $ | — | | $ | 9,092 | -7 | | | | | | |
Liabilities: | | | | | | | | | | | | | | | | | | | |
| Derivative liabilities (5) | | | | | | | | | | | | | | | | | | | |
| | Interest rate contracts | | $ | — | | $ | 13 | | $ | — | | $ | 13 | | | | | | | |
| | Foreign exchange contracts | | | — | | | 484 | | | — | | | 484 | | | | | | | |
| | Equity contracts | | | — | | | 4 | | | — | | | 4 | | | | | | | |
Total liabilities | | $ | — | | $ | 501 | | $ | — | | $ | 501 | -7 | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
(1) Included within cash and cash equivalents in the Consolidated Statement of Financial Position. |
(2) Commercial paper and certificates of deposit reported as marketable securities in the Consolidated Statement of |
Financial Position. |
(3) Included within investments and sundry assets in the Consolidated Statement of Financial Position. |
(4) The gross balances of derivative assets contained within prepaid expenses and other current assets, and investments |
and sundry assets in the Consolidated Statement of Financial Position at December 31, 2013 were $318 million and |
$401 million, respectively. |
(5) The gross balances of derivative liabilities contained within other accrued expenses and liabilities, and other |
liabilities in the Consolidated Statement of Financial Position at December 31, 2013 were $375 million and $126 |
million, respectively. |
(6) Available-for-sale securities with carrying values that approximate fair value. |
(7) If derivative exposures covered by a qualifying master netting agreement had been netted in the Consolidated |
Statement of Financial Position, the total derivative asset and liability positions would have been reduced by $251 |
million each. |
|
There were no transfers between Levels 1 and 2 for the three months ended March 31, 2014 and the year ended December 31, 2013. |
Financial Assets and Liabilities Not Measured at Fair Value |
|
Short-Term Receivables and Payables |
|
Notes and other accounts receivable and other investments are financial assets with carrying values that approximate fair value. Accounts payable, other accrued expenses and short-term debt (excluding the current portion of long-term debt) are financial liabilities with carrying values that approximate fair value. If measured at fair value in the financial statements, these financial instruments would be classified as Level 3 in the fair value hierarchy. |
|
Loans and Long-term Receivables |
|
Fair values are based on discounted future cash flows using current interest rates offered for similar loans to clients with similar credit ratings for the same remaining maturities. At March 31, 2014 and December 31, 2013, the difference between the carrying amount and estimated fair value for loans and long-term receivables was immaterial. If measured at fair value in the financial statements, these financial instruments would be classified as Level 3 in the fair value hierarchy. |
|
Long-term Debt |
|
Fair value of publicly-traded long-term debt is based on quoted market prices for the identical liability when traded as an asset in an active market. For other long-term debt for which a quoted market price is not available, an expected present value technique that uses rates currently available to the company for debt with similar terms and remaining maturities is used to estimate fair value. The carrying amount of long-term debt was $34,668 million and $32,856 million, and the estimated fair value was $36,808 million and $34,555 million at March 31, 2014 and December 31, 2013, respectively. If measured at fair value in the financial statements, long-term debt (including the current portion) would be classified as Level 2 in the fair value hierarchy. |
|
Debt and Marketable Equity Securities |
|
The company’s cash equivalents and current debt securities are considered available-for-sale and recorded at fair value, which is not materially different from carrying value, in the Consolidated Statement of Financial Position. |
|
During the quarter, the company acquired equity investments in conjunction with the sale of the customer care business which are classified as trading securities. At March 31, 2014, unrealized gains related to trading securities of $6 million were recorded in other (income) and expense in the Consolidated Statement of Earnings. |
|
The following tables summarize the company’s noncurrent debt and marketable equity securities which are also considered available-for-sale and recorded at fair value in the Consolidated Statement of Financial Position. |
| | | | | | | Gross | | Gross | | | | | | | | | | |
(Dollars in millions) | | Adjusted | | Unrealized | | Unrealized | | Fair | | | | | | | |
At March 31, 2014: | | Cost | | Gains | | Losses | | Value | | | | | | | |
Debt securities – noncurrent(1) | | $ | 8 | | $ | 2 | | $ | — | | $ | 9 | | | | | | | |
Available-for-sale equity investments(1) | | $ | 2 | | $ | 2 | | $ | 0 | | $ | 4 | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
(1) Included within investments and sundry assets in the Consolidated Statement of Financial Position. | | | | | | | | |
| | | | | | | Gross | | Gross | | | | | | | | | | |
(Dollars in millions) | | Adjusted | | Unrealized | | Unrealized | | Fair | | | | | | | |
At December 31, 2013: | | Cost | | Gains | | Losses | | Value | | | | | | | |
Debt securities – noncurrent(1) | | $ | 7 | | $ | 1 | | $ | — | | $ | 9 | | | | | | | |
Available-for-sale equity investments(1) | | $ | 20 | | $ | 2 | | $ | 4 | | $ | 18 | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
(1) Included within investments and sundry assets in the Consolidated Statement of Financial Position. | | | | | | | | |
Based on an evaluation of available evidence as of March 31, 2014 and December 31, 2013, the company believes that unrealized losses on debt and available-for-sale equity investments were temporary and did not represent a need for an other-than-temporary impairment. |
|
Sales of debt and available-for-sale equity investments during the period were as follows: |
(Dollars in millions) | | | | | | | | | | | | | | | | | | | | | |
For the three months ended March 31: | | | 2014 | | | 2013 | | | | | | | | | | | | | | | |
Proceeds | | $ | 14 | | $ | 18 | | | | | | | | | | | | | | | |
Gross realized gains (before taxes) | | | — | | | 3 | | | | | | | | | | | | | | | |
Gross realized losses (before taxes) | | | 4 | | | 4 | | | | | | | | | | | | | | | |
(Dollars in millions) | | | | | | | | | | | | | | | | | | | | | |
For the three months ended March 31: | | | 2014 | | | 2013 | | | | | | | | | | | | | | | |
Net unrealized gains/(losses) arising during the period | | $ | 0 | | $ | ($1) | | | | | | | | | | | | | | | |
Net unrealized (gains)/losses reclassified to net income* | | | 3 | | | 0 | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
* There were no writedowns for the three months ended March 31, 2014 and 2013. | | | | | | | | | | | | | | |
The contractual maturities of substantially all available-for-sale debt securities are less than one year at March 31, 2014. |
Derivative Financial Instruments |
|
The company operates in multiple functional currencies and is a significant lender and borrower in the global markets. In the normal course of business, the company is exposed to the impact of interest rate changes and foreign currency fluctuations, and to a lesser extent equity and commodity price changes and client credit risk. The company limits these risks by following established risk management policies and procedures, including the use of derivatives, and, where cost effective, financing with debt in the currencies in which assets are denominated. For interest rate exposures, derivatives are used to better align rate movements between the interest rates associated with the company’s lease and other financial assets and the interest rates associated with its financing debt. Derivatives are also used to manage the related cost of debt. For foreign currency exposures, derivatives are used to better manage the cash flow volatility arising from foreign exchange rate fluctuations. |
|
As a result of the use of derivative instruments, the company is exposed to the risk that counterparties to derivative contracts will fail to meet their contractual obligations. To mitigate the counterparty credit risk, the company has a policy of only entering into contracts with carefully selected major financial institutions based upon their overall credit profile. The company’s established policies and procedures for mitigating credit risk on principal transactions include reviewing and establishing limits for credit exposure and continually assessing the creditworthiness of counterparties. The right of set-off that exists under certain of these arrangements enables the legal entities of the company subject to the arrangement to net amounts due to and from the counterparty reducing the maximum loss from credit risk in the event of counterparty default. |
|
The company is also a party to collateral security arrangements with most of its major derivative counterparties. These arrangements require the company to hold or post collateral (cash or U.S. Treasury securities) when the derivative fair values exceed contractually established thresholds. Posting thresholds can be fixed or can vary based on credit default swap pricing or credit ratings received from the major credit agencies. The aggregate fair value of all derivative instruments under these collateralized arrangements that were in a liability position at March 31, 2014 and December 31, 2013 was $201 million and $216 million, respectively, for which no collateral was posted at March 31, 2014 and December 31, 2013. Full collateralization of these agreements would be required in the event that the company’s credit rating falls below investment grade or if its credit default swap spread exceeds 250 basis points, as applicable, pursuant to the terms of the collateral security arrangements. The aggregate fair value of derivative instruments in net asset positions as of March 31, 2014 and December 31, 2013 was $678 million and $719 million, respectively. This amount represents the maximum exposure to loss at the reporting date as a result of the counterparties failing to perform as contracted. This exposure was reduced by $221 million and $251 million at March 31, 2014 and December 31, 2013, respectively, of liabilities included in master netting arrangements with those counterparties. Additionally, at March 31, 2014 and December 31, 2013, this exposure was reduced by $23 million and $29 million of cash collateral, respectively, received by the company. At March 31, 2014 and December 31, 2013, the net exposure related to derivative assets recorded in the Consolidated Statement of Financial Position was $434 million and $439 million, respectively. At March 31, 2014 and December 31, 2013, the net amount related to derivative liabilities recorded in the Consolidated Statement of Financial Position was $220 million and $250 million, respectively. |
|
In the Consolidated Statement of Financial Position, the company does not offset derivative assets against liabilities in master netting arrangements nor does it offset receivables or payables recognized upon payment or receipt of cash collateral against the fair values of the related derivative instruments. No amount was recognized in other receivables at March 31, 2014 or December 31, 2013 for the right to reclaim cash collateral. The amount recognized in accounts payable for the obligation to return cash collateral totaled $23 million and $29 million at March 31, 2014 and December 31, 2013, respectively. The company restricts the use of cash collateral received to rehypothecation, and therefore reports it in prepaid expenses and other current assets in the Consolidated Statement of Financial Position. No amount was rehypothecated at March 31, 2014 or at December 31, 2013. At March 31, 2014 and December 31, 2013, no amounts of non-cash collateral were held. |
|
The company may employ derivative instruments to hedge the volatility in stockholders’ equity resulting from changes in currency exchange rates of significant foreign subsidiaries of the company with respect to the U.S. dollar. These instruments, designated as net investment hedges, expose the company to liquidity risk as the derivatives have an immediate cash flow impact upon maturity which is not offset by a cash flow from the translation of the underlying hedged equity. The company monitors this cash loss potential on an ongoing basis and may discontinue some of these hedging relationships by de-designating or terminating the derivative instrument in order to manage the liquidity risk. Although not designated as accounting hedges, the company may utilize derivatives to offset the changes in the fair value of the de-designated instruments from the date of de-designation until maturity. |
|
In its hedging programs, the company uses forward contracts, futures contracts, interest-rate swaps and cross-currency swaps, depending upon the underlying exposure. The company is not a party to leveraged derivative instruments. |
|
A brief description of the major hedging programs, categorized by underlying risk, follows. |
|
Interest Rate Risk |
|
Fixed and Variable Rate Borrowings |
|
The company issues debt in the global capital markets, principally to fund its financing lease and loan portfolios. Access to cost-effective financing can result in interest rate mismatches with the underlying assets. To manage these mismatches and to reduce overall interest cost, the company uses interest-rate swaps to convert specific fixed-rate debt issuances into variable-rate debt (i.e., fair value hedges) and to convert specific variable-rate debt issuances into fixed-rate debt (i.e., cash flow hedges). At March 31, 2014 and December 31, 2013, the total notional amount of the company’s interest rate swaps was $5.9 billion and $3.1 billion, respectively. The weighted-average remaining maturity of these instruments at March 31, 2014 and December 31, 2013 was approximately 9.5 years and 10.6 years, respectively. |
|
Forecasted Debt Issuance |
|
The company is exposed to interest rate volatility on future debt issuances. To manage this risk, the company may use forward starting interest-rate swaps to lock in the rate on the interest payments related to the forecasted debt issuance. These swaps are accounted for as cash flow hedges. The company did not have any derivative instruments relating to this program outstanding at March 31, 2014 and December 31, 2013. |
|
At March 31, 2014 and December 31, 2013, net gains of approximately $1 million (before taxes), respectively, were recorded in accumulated other comprehensive income/(loss) in connection with cash flow hedges of the company’s borrowings. Within these amounts, gains of less than $1 million, respectively, are expected to be reclassified to net income within the next 12 months, providing an offsetting economic impact against the underlying transactions. |
|
Foreign Exchange Risk |
|
Long-Term Investments in Foreign Subsidiaries (Net Investment) |
|
A large portion of the company’s foreign currency denominated debt portfolio is designated as a hedge of net investment in foreign subsidiaries to reduce the volatility in stockholders’ equity caused by changes in foreign currency exchange rates in the functional currency of major foreign subsidiaries with respect to the U.S. dollar. The company also uses cross-currency swaps and foreign exchange forward contracts for this risk management purpose. At March 31, 2014 and December 31, 2013, the total notional amount of derivative instruments designated as net investment hedges was $3.4 billion and $3.0 billion, respectively. The weighted-average remaining maturity of these instruments at March 31, 2014 and December 31, 2013 was approximately 0.4 years for both periods. |
|
Anticipated Royalties and Cost Transactions |
|
The company’s operations generate significant nonfunctional currency, third-party vendor payments and intercompany payments for royalties and goods and services among the company’s non-U.S. subsidiaries and with the parent company. In anticipation of these foreign currency cash flows and in view of the volatility of the currency markets, the company selectively employs foreign exchange forward contracts to manage its currency risk. These forward contracts are accounted for as cash flow hedges. The maximum length of time over which the company is hedging its exposure to the variability in future cash flows is four years. At March 31, 2014 and December 31, 2013, the total notional amount of forward contracts designated as cash flow hedges of forecasted royalty and cost transactions was $10.2 billion with a weighted-average remaining maturity of 0.7 years for both periods. |
|
At March 31, 2014 and December 31, 2013, in connection with cash flow hedges of anticipated royalties and cost transactions, the company recorded net losses of $169 million and $252 million (before taxes), respectively, in accumulated other comprehensive income/(loss). Within these amounts, $155 million and $166 million of losses, respectively, are expected to be reclassified to net income within the next 12 months, providing an offsetting economic impact against the underlying anticipated transactions. |
|
|
|
Foreign Currency Denominated Borrowings |
|
The company is exposed to exchange rate volatility on foreign currency denominated debt. To manage this risk, the company employs cross-currency swaps to convert fixed-rate foreign currency denominated debt to fixed-rate debt denominated in the functional currency of the borrowing entity. These swaps are accounted for as cash flow hedges. Currently, the maximum length of time over which the company has hedged its exposure to variability in future cash flows is approximately seven years. At March 31, 2014 and December 31, 2013, the total notional amount of cross currency swaps designated as cash flow hedges of foreign currency denominated debt was $1.2 billion for both periods. |
|
At March 31, 2014 and December 31, 2013, in connection with cash flow hedges of foreign currency denominated borrowings, the company recorded net losses of $6 million (before taxes) and $9 million (before taxes), respectively, in accumulated other comprehensive income/(loss). Within these amounts, $3 million of losses in both periods is expected to be reclassified to net income within the next 12 months, providing an offsetting economic impact against the underlying exposure. |
|
Subsidiary Cash and Foreign Currency Asset/Liability Management |
|
The company uses its Global Treasury Centers to manage the cash of its subsidiaries. These centers principally use currency swaps to convert cash flows in a cost-effective manner. In addition, the company uses foreign exchange forward contracts to economically hedge, on a net basis, the foreign currency exposure of a portion of the company’s nonfunctional currency assets and liabilities. The terms of these forward and swap contracts are generally less than one year. The changes in the fair values of these contracts and of the underlying hedged exposures are generally offsetting and are recorded in other (income) and expense in the Consolidated Statement of Earnings. At March 31, 2014 and December 31, 2013, the total notional amount of derivative instruments in economic hedges of foreign currency exposure was $16.3 billion and $14.7 billion, respectively. |
|
Equity Risk Management |
|
The company is exposed to market price changes in certain broad market indices and in the company’s own stock primarily related to certain obligations to employees. Changes in the overall value of these employee compensation obligations are recorded in selling, general and administrative (SG&A) expense in the Consolidated Statement of Earnings. Although not designated as accounting hedges, the company utilizes derivatives, including equity swaps and futures, to economically hedge the exposures related to its employee compensation obligations. The derivatives are linked to the total return on certain broad market indices or the total return on the company’s common stock, and are recorded at fair value with gains or losses also reported in SG&A expense in the Consolidated Statement of Earnings. At March 31, 2014 and December 31, 2013, the total notional amount of derivative instruments in economic hedges of these compensation obligations was $1.2 billion and $1.3 billion, respectively. |
|
Other Risks |
|
The company may hold warrants to purchase shares of common stock in connection with various investments that are deemed derivatives because they contain net share or net cash settlement provisions. The company records the changes in the fair value of these warrants in other (income) and expense in the Consolidated Statement of Earnings. The company did not have any warrants qualifying as derivatives outstanding at March 31, 2014 and December 31, 2013. |
|
The company is exposed to a potential loss if a client fails to pay amounts due under contractual terms. The company may utilize credit default swaps to economically hedge its credit exposures. The swaps are recorded at fair value with gains and losses reported in other (income) and expense in the Consolidated Statement of Earnings. The company did not have any derivative instruments relating to this program outstanding at March 31, 2014 and December 31, 2013. |
|
The following tables provide a quantitative summary of the derivative and non-derivative instrument- related risk management activity as of March 31, 2014 and December 31, 2013 as well as for the three months ended March 31, 2014 and 2013, respectively: |
Fair Values of Derivative Instruments in the Consolidated Statement of Financial Position | | | | | | |
As of March 31, 2014 and December 31, 2013 | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
(Dollars in millions) | Fair Value of Derivative Assets | | Fair Value of Derivative Liabilities | | | | | | |
| Balance Sheet | | | | | | | | Balance Sheet | | | | | | | | | | | | |
| Classification | | 3/31/14 | | 12/31/13 | | Classification | | 3/31/14 | | 12/31/13 | | | | | | |
Designated as hedging | | | | | | | | | | | | | | | | | | | | | |
instruments: | | | | | | | | | | | | | | | | | | | | | |
Interest rate contracts: | Prepaid expenses and | | | | | | | | Other accrued | | | | | | | | | | | | |
| other current assets | | $ | — | | $ | — | | expenses and liabilities | | $ | — | | $ | 0 | | | | | | |
| Investments and sundry | | | | | | | | | | | | | | | | | | | | |
| assets | | | 363 | | | 308 | | Other liabilities | | | 12 | | | 13 | | | | | | |
Foreign exchange | Prepaid expenses and | | | | | | | | Other accrued | | | | | | | | | | | | |
contracts: | other current assets | | | 110 | | | 187 | | expenses and liabilities | | | 270 | | | 331 | | | | | | |
| Investments and sundry | | | | | | | | | | | | | | | | | | | | |
| assets | | | 54 | | | 26 | | Other liabilities | | | 55 | | | 112 | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
Fair value of derivative | | | | | | | | | Fair value of derivative | | | | | | | | | | | | |
assets | | | $ | 528 | | $ | 522 | | liabilities | | $ | 337 | | $ | 456 | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
Not designated as | | | | | | | | | | | | | | | | | | | | | |
hedging instruments: | | | | | | | | | | | | | | | | | | | | | |
Foreign exchange | Prepaid expenses and | | | | | | | | Other accrued | | | | | | | | | | | | |
contracts: | other current assets | | $ | 74 | | $ | 94 | | expenses and liabilities | | $ | 98 | | $ | 40 | | | | | | |
| Investments and sundry | | | | | | | | | | | | | | | | | | | | |
| assets | | | 59 | | | 67 | | Other liabilities | | | 4 | | | 1 | | | | | | |
Equity contracts: | Prepaid expenses and | | | | | | | | Other accrued | | | | | | | | | | | | |
| other current assets | | | 17 | | | 36 | | expenses and liabilities | | | 2 | | | 4 | | | | | | |
Fair value of derivative | | | | | | | | | Fair value of derivative | | | | | | | | | | | | |
assets | | | $ | 151 | | $ | 197 | | liabilities | | $ | 104 | | $ | 45 | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
Total debt designated as | | | | | | | | | | | | | | | | | | | | | |
hedging instruments: | | | | | | | | | | | | | | | | | | | | | |
| Short-term debt | | | N/A | | | N/A | | | | $ | — | | $ | 190 | | | | | | |
| Long-term debt | | | N/A | | | N/A | | | | | 6,116 | | | 6,111 | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
Total | | | $ | 678 | | $ | 719 | | | | $ | 6,557 | | $ | 6,802 | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
N/A-not applicable | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
The Effect of Derivative Instruments in the Consolidated Statement of Earnings | | | | | | |
For the three months ended March 31, 2014 and 2013 | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
(Dollars in millions) | | Gain (Loss) Recognized in Earnings | | | | | | |
| | | Consolidated | | | | | | | | | | | | | | | | | | |
| | | Statement of | | Recognized on | | Attributable to Risk | | | | | | |
| | | Earnings Line Item | | Derivatives(1) | | Being Hedged(2) | | | | | | |
For the three months ended March 31: | | | | | 2014 | | | 2013 | | | 2014 | | | 2013 | | | | | | |
Derivative instruments in fair value hedges: | | | | | | | | | | | | | | | | | | | | |
Interest rate contracts | | Cost of financing | | $ | 48 | | $ | -20 | | $ | -23 | | $ | 46 | | | | | | |
| | | Interest expense | | | 33 | | | -13 | | | -15 | | | 30 | | | | | | |
Derivative instruments not designated as | | | | | | | | | | | | | | | | | | | | |
| hedging instruments(1): | | | | | | | | | | | | | | | | | | | | |
Foreign exchange contracts | | Other (income) | | | | | | | | | | | | | | | | | | |
| | | and expense | | | -34 | | | -439 | | | N/A | | | N/A | | | | | | |
Equity contracts | | SG&A expense | | | 21 | | | 85 | | | N/A | | | N/A | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
Total | | | | $ | 68 | | $ | -387 | | $ | -38 | | $ | 76 | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
| | | Gain (Loss) Recognized in Earnings and Other Comprehensive Income |
| | | | | | Consolidated | | | | | | | | (Ineffectiveness) and |
| | | Effective Portion | | Statement of | | Effective Portion Reclassified | | Amounts Excluded from |
| | | Recognized in OCI | | Earnings Line Item | | from AOCI | | Effectiveness Testing(3) |
For the three months | | | | | | | | | | | | | | | | |
| ended March 31: | | 2014 | | 2013 | | | | 2014 | | 2013 | | 2014 | | 2013 |
Derivative instruments | | | | | | | | | | | | | | | | | | | | |
| in cash flow hedges: | | | | | | | | | | | | | | | | | | | | |
Interest rate contracts | | $ | — | | $ | — | | Interest expense | | $ | — | | $ | — | | $ | — | | $ | — |
| | | | | | | | | Other (income) | | | | | | | | | | | | |
Foreign exchange | | | 88 | | | 360 | | and expense | | | 29 | | | 37 | | | 0 | | | 1 |
| contracts | | | | | | | | Cost of sales | | | -26 | | | 9 | | | — | | | — |
| | | | | | | | | SG&A expense | | | -2 | | | 10 | | | — | | | — |
Instruments in net | | | | | | | | | | | | | | | | | | | | |
| investment hedges(4): | | | | | | | | | | | | | | | | | | | | |
Foreign exchange | | | | | | | | | | | | | | | | | | | | |
| contracts | | | -26 | | | 219 | | Interest expense | | | — | | | — | | | 0 | | | -1 |
| | | | | | | | | | | | | | | | | | | | | |
Total | | $ | 62 | | $ | 579 | | | | $ | 1 | | $ | 56 | | $ | 0 | | $ | 0 |
N/A-not applicable |
|
Note: OCI represents Other comprehensive income/(loss) in the Consolidated Statement of Comprehensive Income and AOCI represents Accumulated other comprehensive income/(loss) in the Consolidated Statement of Changes in Equity. |
|
The amount includes changes in clean fair values of the derivative instruments in fair value hedging relationships and the periodic accrual for coupon payments required under these derivative contracts. |
The amount includes basis adjustments to the carrying value of the hedged item recorded during the period and amortization of basis adjustments recorded on de-designated hedging relationships during the period. |
The amount of gain (loss) recognized in income represents ineffectiveness on hedge relationships. |
Instruments in net investment hedges include derivative and non-derivative instruments |
|
For the three months ending March 31, 2014 and 2013, there were no significant gains or losses recognized in earnings representing hedge ineffectiveness or excluded from the assessment of hedge effectiveness (for fair value hedges), or associated with an underlying exposure that did not or was not expected to occur (for cash flow hedges); nor are there any anticipated in the normal course of business. |
|
Refer to the company’s 2013 Annual Report, Note A, “Significant Accounting Policies – Derivative Financial Instruments,” on pages 90 to 91 for additional information. |